Otros idiomas PAO Group, Inc.

Acciones

PAOG

US6986681004

Diferido OTC Markets Otros sitios de cotización 15:47:52 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0005 ^USD	0,00 %		-16,67 %	0,00 %

2022	La colaboración entre PURA y PAOG CBD Nutraceutical se destaca en el 420 Update de mañana	CI
2022	Puration, Inc. y PAO Group, Inc. Lanzarán el mes que viene una línea de productos de CBD para el mercado de la salud femenina, de 40.000 millones de dólares	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

PAO : PAOG 2022 SECOND QUARTER REPORT AND DISCLOSURE	14/08/22
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow	19/04/22
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow	19/04/22
PURA Hemp Crypto Carbon Credit and Asian Expansion On Track	06/04/22
PURA and PAOG On Track To Launch CBD Product Line For $40 Billion Women’s Health Market	05/04/22
PURA Confirms New CBD Product Line For $40 Billion Women’s Health Market	22/03/22
PURA and PAOG To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market	17/03/22
Puration, Inc. and PAO Group, Inc. To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market	17/03/22
PURA Expects To Boost Revenue Entering $17 Billion CBD Nutraceutical Market	14/03/22
PURA and PAOG Plan Sneak Peek Of CBD Nutraceutical Product Line For $17 Billion Market Opportunity	11/03/22
CapitalGainsReport: CBD Beverages Expected to Drive Growth in Broader CBD Market (RLBD, KGKG, PURA, PAOG, HIPH)	09/03/22
PURA and PAOG Plan Joint CBD Nutraceutical Product Line Launch Next Month	08/03/22
Puration, Inc and PAO Group, Inc Plan Joint Cbd Nutraceutical Product Line Launch Next Month	08/03/22
PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign	03/02/22
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development	01/02/22
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development	01/02/22
PAOG Publishes 2022 Strategic Update	28/01/22
PAOG Publishes 2022 Strategic Update	28/01/22
PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development	25/01/22
PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA	06/01/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas PAO Group, Inc.

Acciones

PAOG

US6986681004

Otros idiomas

Filtros